Village Global

Atmosfy is a platform founded in 2021 and based in San Francisco, California, that specializes in discovering dining and nightlife options through video content. The platform allows users to explore various establishments, such as restaurants, bars, nightclubs, and cafes, both locally and from afar. Atmosfy enhances the decision-making process for users by providing video-based insights along with reviews and recommendations for each venue. This approach enables individuals to make informed choices about where to dine or socialize based on their personal preferences.

Tinycare is a network of modern daycare centers focused on providing high-quality care for infants, toddlers, and preschoolers in San Francisco. Founded in 2018 by Michael Lai, Tinycare aims to create the safest and cleanest environments for early childhood education. The centers adopt a progressive approach to learning, designed to help each child reach their full potential while offering parents peace of mind. By prioritizing licensed care and a supportive atmosphere, Tinycare addresses the growing need for reliable daycare options in the region.

Orchid is a reproductive technology startup founded in 2019 and headquartered in San Francisco, California. The company specializes in detecting rare genetic disorders through its preconception system, which analyzes the genomes of both partners to assess genetic predispositions to various diseases, including heart disease, Alzheimer’s, and certain types of cancer. Orchid provides a “Couple Report” that incorporates results from an at-home saliva test, allowing couples to understand the potential genetic risks for their future children. If elevated risks are identified, Orchid offers valuable insights to guide couples in monitoring health markers, adjusting their diets, or considering procedures such as in vitro fertilization. The company collaborates with experts in reproductive medicine and genetics to ensure the accuracy of its results.

Roam Research is a tool that offers services for notetaking and graph databases. Roam Research believes that writing is a tool for thinking. If we can build a tool for helping people write and organize their ideas more effectively, we can help them have better thoughts and solve otherwise intractable problems. The company was founded in 2017 and is based in San Francisco, California, United States.

Tinycare is a network of modern daycare centers focused on providing high-quality care for infants, toddlers, and preschoolers in San Francisco. Founded in 2018 by Michael Lai, Tinycare aims to create the safest and cleanest environments for early childhood education. The centers adopt a progressive approach to learning, designed to help each child reach their full potential while offering parents peace of mind. By prioritizing licensed care and a supportive atmosphere, Tinycare addresses the growing need for reliable daycare options in the region.

Photon Commerce is a San Francisco-based company founded in 2020 that specializes in AI-as-a-Service for B2B SaaS providers. It offers a white-labeled platform that automates document understanding and supply chain collaboration, focusing on streamlining invoicing, receipts, and payment data. By utilizing generative AI and optical character recognition (OCR), Photon Commerce enables businesses to convert complex data from various sources, such as paper documents and PDFs, into a centralized analytics dashboard. This technology helps companies in logistics, e-commerce, and other sectors reduce labor costs, minimize errors, and enhance operational efficiency. Photon Commerce's services include features like 1-click Accounts Payable and Accounts Receivable, designed to facilitate instant product experiences and decision analysis for business leaders. The company is backed by notable investors, including the Nasdaq Center and Village Global.

Kapwing Inc. is an online platform that provides tools for image, video, and GIF editing, catering primarily to content creators. Founded in 2017 and based in San Francisco, California, Kapwing offers a suite of multimedia editing tools, including a meme maker, subtitle maker, trimmer, looper, and various filters. The platform is designed to facilitate collaborative content creation, allowing users to edit and share their stories seamlessly from any device in the cloud. By focusing on empowering digital storytellers, Kapwing supports media companies in scaling their content production and enhances the efficiency of non-linear editing workflows.

Rune Labs, Inc. is a San Francisco-based company that develops a software-as-a-service platform focused on neuromodulation systems to enhance the management of complex therapies. Founded in 2018, the platform processes brain imaging and electrophysiology data from clinical studies and patient care, making it valuable for neuroscience therapeutics. It supports pharmaceutical companies in creating and implementing precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The cloud-based platform allows therapy developers to efficiently manage data and run complex algorithms across multiple patients, facilitating the delivery of precision medicine and identifying potential responders for clinical trials. By integrating with emerging neuromodulation devices, Rune Labs enables clients to leverage large datasets for therapy development and adaptive therapy applications.

VeriSIM Life, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing disease-specific biosimulation models to enhance drug development processes. Founded in 2017, the company utilizes its proprietary BIOiSIM platform to predict the clinical outcomes of new drugs prior to clinical trials, thereby replacing traditional animal testing methods. By employing artificial intelligence, VeriSIM Life aims to improve the accuracy and efficiency of drug development, ultimately contributing to personalized healthcare solutions. Their offerings are tailored to meet the needs of both pre-clinical and clinical programs, focusing on small molecules, large molecules, and viruses to facilitate better treatment options and increase human life expectancy.

Bravado is a community platform aimed at sales professionals, founded in 2017 and headquartered in San Francisco, California. It provides online tools and organizes in-person events to assist its members in amplifying their voices, enhancing their personal brands, and connecting with peers in the sales industry. The platform emphasizes customer endorsements, establishing a trusted network that enables sales professionals to generate referrals and develop their careers effectively. Through its resources, Bravado seeks to empower individuals in the sales field to excel in their roles and foster meaningful professional relationships.

DFINITY Foundation is a not-for-profit organization based in Zurich, Switzerland, with additional offices in San Francisco, California. Founded in 2016, it focuses on developing the Internet Computer, a decentralized cloud platform designed to facilitate the creation and hosting of web applications. The foundation is a key contributor to the Internet Computer Protocol (ICP), which enables independent data centers to collaborate and provide secure, serverless cloud functionality. DFINITY also offers the Canister software development kit (SDK) to assist users in building applications on this platform. By leveraging blockchain technology, DFINITY aims to simplify the development of sophisticated web applications, allowing non-technical users to create and manage these tools through natural language interactions. This vision seeks to transform the internet into a decentralized "World Computer," enhancing security and promoting the adoption of Web3 technologies. The foundation operates research centers in multiple locations, including Palo Alto and Shanghai, driving innovation within its ecosystem.

VeriSIM Life, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing disease-specific biosimulation models to enhance drug development processes. Founded in 2017, the company utilizes its proprietary BIOiSIM platform to predict the clinical outcomes of new drugs prior to clinical trials, thereby replacing traditional animal testing methods. By employing artificial intelligence, VeriSIM Life aims to improve the accuracy and efficiency of drug development, ultimately contributing to personalized healthcare solutions. Their offerings are tailored to meet the needs of both pre-clinical and clinical programs, focusing on small molecules, large molecules, and viruses to facilitate better treatment options and increase human life expectancy.